Biohaven (BHVN) Competitors $15.86 -0.35 (-2.16%) As of 12:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BHVN vs. ABVX, RNA, AXSM, NUVL, MRUS, CRSP, TGTX, CYTK, ACAD, and KRYSShould you be buying Biohaven stock or one of its competitors? The main competitors of Biohaven include Abivax (ABVX), Avidity Biosciences (RNA), Axsome Therapeutics (AXSM), Nuvalent (NUVL), Merus (MRUS), CRISPR Therapeutics (CRSP), TG Therapeutics (TGTX), Cytokinetics (CYTK), ACADIA Pharmaceuticals (ACAD), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry. Biohaven vs. Its Competitors Abivax Avidity Biosciences Axsome Therapeutics Nuvalent Merus CRISPR Therapeutics TG Therapeutics Cytokinetics ACADIA Pharmaceuticals Krystal Biotech Biohaven (NYSE:BHVN) and Abivax (NASDAQ:ABVX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends. Do analysts rate BHVN or ABVX? Biohaven presently has a consensus price target of $55.71, suggesting a potential upside of 250.91%. Abivax has a consensus price target of $92.33, suggesting a potential upside of 8.89%. Given Biohaven's higher probable upside, research analysts plainly believe Biohaven is more favorable than Abivax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biohaven 0 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 3 Strong Buy rating(s) 3.13Abivax 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Is BHVN or ABVX more profitable? Abivax's return on equity of 0.00% beat Biohaven's return on equity.Company Net Margins Return on Equity Return on Assets BiohavenN/A -270.65% -143.70% Abivax N/A N/A N/A Does the media prefer BHVN or ABVX? In the previous week, Biohaven had 29 more articles in the media than Abivax. MarketBeat recorded 39 mentions for Biohaven and 10 mentions for Abivax. Abivax's average media sentiment score of 1.06 beat Biohaven's score of 0.49 indicating that Abivax is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biohaven 11 Very Positive mention(s) 2 Positive mention(s) 23 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Abivax 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, BHVN or ABVX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiohavenN/AN/A-$846.42M-$7.66-2.07AbivaxN/AN/A-$190.71MN/AN/A Which has more volatility & risk, BHVN or ABVX? Biohaven has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Abivax has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Do institutionals & insiders hold more shares of BHVN or ABVX? 88.8% of Biohaven shares are held by institutional investors. Comparatively, 47.9% of Abivax shares are held by institutional investors. 14.6% of Biohaven shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryBiohaven beats Abivax on 7 of the 11 factors compared between the two stocks. Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHVN vs. The Competition Export to ExcelMetricBiohavenMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.68B$3.10B$5.76B$21.26BDividend YieldN/A2.28%6.66%3.49%P/E Ratio-2.0720.9382.4829.30Price / SalesN/A367.07500.4146.19Price / CashN/A43.5325.7018.29Price / Book12.508.0510.815.28Net Income-$846.42M-$53.35M$3.28B$998.51M7 Day Performance2.36%-0.93%-0.43%-0.39%1 Month Performance8.04%5.97%6.47%5.18%1 Year Performance-58.06%10.33%49.57%14.23% Biohaven Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHVNBiohaven3.8559 of 5 stars$15.86-2.2%$55.71+251.3%-57.5%$1.68BN/A-2.07239Trending NewsAnalyst ForecastABVXAbivax3.2547 of 5 stars$77.46+0.2%$92.33+19.2%+574.1%$5.85BN/A0.0061News CoveragePositive NewsShort Interest ↓RNAAvidity Biosciences3.1991 of 5 stars$45.27-2.3%$67.00+48.0%+16.1%$5.82B$10.90M-12.72190Positive NewsAXSMAxsome Therapeutics4.7729 of 5 stars$116.31-1.9%$178.00+53.0%+36.1%$5.80B$495.03M-22.94380News CoveragePositive NewsAnalyst ForecastInsider TradeNUVLNuvalent3.2422 of 5 stars$74.05-2.7%$118.91+60.6%-4.9%$5.34BN/A-15.1140News CoveragePositive NewsAnalyst ForecastMRUSMerus3.0238 of 5 stars$65.74-2.6%$88.64+34.8%+32.0%$4.97B$56.23M-11.9537News CoveragePositive NewsCRSPCRISPR Therapeutics3.5882 of 5 stars$54.13-0.3%$71.60+32.3%+16.4%$4.92B$35M-9.97460Analyst RevisionTGTXTG Therapeutics4.3988 of 5 stars$28.53-3.1%$46.25+62.1%+40.2%$4.53B$454.07M77.11290News CoveragePositive NewsCYTKCytokinetics4.1774 of 5 stars$37.01-3.5%$71.58+93.4%-8.4%$4.43B$18.47M-7.26250Trending NewsAnalyst ForecastInsider TradeOptions VolumeACADACADIA Pharmaceuticals4.0426 of 5 stars$25.32-1.6%$28.88+14.0%+57.2%$4.27B$1.02B19.04510Analyst RevisionKRYSKrystal Biotech4.8404 of 5 stars$146.77-2.5%$210.38+43.3%-19.6%$4.25B$359.21M29.83210Positive News Related Companies and Tools Related Companies Abivax Alternatives Avidity Biosciences Alternatives Axsome Therapeutics Alternatives Nuvalent Alternatives Merus Alternatives CRISPR Therapeutics Alternatives TG Therapeutics Alternatives Cytokinetics Alternatives ACADIA Pharmaceuticals Alternatives Krystal Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHVN) was last updated on 9/4/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
